Recognized Pharmacopoeia in Registration system

Similar documents
Pharmakon drug Poiea to make Government of each country List of Pharmacopeias: British European Indian International United state.

Agenda. The current state of Pharmaceutical Excipients in Japan -JPE, JP, DMF, GAB (GMP Auditing Board)- Pharmaceutical Excipients

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE

Residual Solvents: FDA/ Regulatory Perspective

State Pharmacopoeia of Ukraine

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Indian Pharmacopoeia Commission

Kazuhiko Mori Ministry of Health, Labour and Welfare

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

SLEEP AIDS - LABELLING STANDARD

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

USP Perspective on Atypical Actives November 29, 2017

Requirements to the Registration of Medicinal products in the Republic of Armenia

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

FOOD AND DRUGS AUTHORITY (FDA) GHANA

MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

New Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs

Regulatory & Quality Control Provisions for Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) Drugs

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Compounding Medication Regulations

December 4, 2017 VIA ELECTRONIC SUBMISSION

Organic Impurities in Drug Substances and Drug Products. Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 8, 2017

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry

Overview of USP General Chapters <476> and <1086> Prescription/Non-Prescription Stakeholder Forum October 19, 2017

Guideline on the Regulation of Therapeutic Products in New Zealand

Dr. Tipvon Parinyasiri

Food additives. FAO guidelines on the structure and content of the document called "Chemical and Technical Assessment (CTA)" Rome, February 2003

Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

The International Pharmacopoeia - Overview

Measuring Emissions as Part of a Regulatory Regime. Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4

Japan's Regulation of Food Additives

Public manual: Application for permission of a product and correction of permitted items: for food for weight control person Service agency:

General concepts in the Ph. Eur.: theory and rationale

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

ILSI SEA Region 10th Seminar on Nutrition Labeling, Claims and Communication Strategies, August 28-29, 2018, KL, Malaysia

GOVERNMENT OF REPUBLIC OF TRINIDAD AND TOBAGO MINISTRY OF HEALTH CHEMIST- FOOD AND DRUGS DIVISION NEW DRUG SUBMISSION FORM

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines

American Herbal Pharmacopoeia's Botanical Microscopy Text Named Recipient of ABC's James A. Duke Award for Excellence in Botanical Literature

- Notification to specify uniform limit (Ministry of Health, Labour and Welfare Notification No. 497, 2005)

EFFECTIVE DATE: 05/02/2017

GOOD PHARMACOPOEIAL PRACTICES

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

The right choice for your health

Vol. 41(1) [Jan. Feb. 2015] (P) \\uspnetapp2\share\share\uspnf\printq\pager\xmlin\lyc_ _m99989.xml. Nov.

Guidance on Limits of Foreign Matter in Herbal Ingredients

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

The State Pharmacopoeia of the Russian Federation

10 th Seminar on. Nutrition Labeling, Claims and Communication Strategies. Nutrition Labelling and Claims in India An Update

Thailand s experience in developing the Reclassification guideline

M I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents

The Complexity of Setting Compendial Specifications for Excipient Composition and Impurities

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

REGULATION (EC) No.141/2000

COMPLETION OF THE CTD IN APPLICATION FOR A COMPLEMENTARY MEDICINE

The Second Draft of Provisional Maximum Residue Limits (MRLs) for Agricultural Chemicals in Foods

MEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA

INDIAN PHARMACOPOEIA PDF

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES

Questions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to

Recall Guidelines. for Chinese Medicine Products

IMPLEMENTATION OF THE REVISED GENERAL

CHASTE TREE. Vitex agnus-castus L. (Lamiaceae) (McGuffin et al. 2000; USDA 1998) Source material(s): Fruit/Berry (Blumenthal 2000; Mills & Bone 2000)

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years

Market Authorization of Traditional Medicine: A Global Scenario

Interchangeable Drug Products - Additional Criteria

Update on JP-TW OTC drugs WG

ISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.

The European Union CD 1999/83/EEC on well-established use

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

Review of Controlled Drugs and Substances Act

QUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS

2. Review of literature: 2.1 General review on methods of simultaneous determination of hypertensive drugs.

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.

COMMITTEE ON WORLD FOOD SECURITY

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Food and Drug Regulations - Project Number Schedule F

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.

National Policy on Traditional / Complementary Medicine, Malaysia Ministry of Health Malaysia August 2002

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Development of risk-based standard on aflatoxin in peanuts

2.1 National Economic and Social Development Plans

USP Excipients Standards Setting Process

Module 34: Legal aspects, ADI and GRAS status of food additives

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

16 February Cannabis Standards and their relationship to Clinical Health Outcomes

Developments in regulations for complementary medicines (including traditional medicines and other natural health products)

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Particular challenges of evaluation of herbal combination products

How to change the legal classification of a medicine in New Zealand

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

Transcription:

Recognized Pharmacopoeia in Registration system Mrs. Prapassorn THANAPHOLLERT Acting Director, Bureau of Control Food and, THAILAND

What is pharmacopoeia? Legal basis Outline Recognized Official Pharmacopoeia Thai Pharmacopoeia, Thai Herbal Pharmacopoeia Benefit of the recognized official pharmacopoeia Process for updating recognized Official Pharmacopoeia Criteria in recognition of pharmacopoeia

What is pharmacopoeia? -a book containing an official list of medicinal drugs together with articles on their preparation and use. -an authoritative book containing a list of medicinal drugs with their uses, preparation, dosages, formulas, etc. -a book described drugs; one issued by an officially recognized authority and serving as standard

What is pharmacopoeia? -a work containing monographs of therapeutic agents, standards for their strength and purity, and their formulations. -The various national pharmacopeias are referred to by abbreviations, of which the following are the most frequently encountered: USP, BP, JP, TP, IP, Ph.Eur

Legal basis Article 4 (1) of Act B.E.2510 (1967) defines as any substance listed in the official pharmacopoeia as announced by the Minister Chapter 9 of Acts B.E. 2510 (1967) Notice concerning s Article 76 (1): empowers Minister of Public Health to publish Official Pharmacopoeia in Royal Thai Gazette

Legal basis Article 78: The Ministerial Notification could be done based on recommendation from Committee Chapter 10 of Act B.E.2510(1967) Registration Article 80(4): Application for modern drug registration shall be accompanied with analytical control method if the non-official compendia method will be used

Recognized Official Pharmacopoeia Ministerial Notification : Official Pharmacopoeia B.E. 2519 Ministerial Notification : Official Pharmacopoeia B.E. 2531 Ministerial Notification : Official Pharmacopoeia B.E. 2539 Ministerial Notification : Official Pharmacopoeia B.E. 2541 Ministerial Notification : Official Pharmacopoeia B.E. 2543 Ministerial Notification : Official Pharmacopoeia B.E. 2544

Recognized Official Pharmacopoeia Ministerial Notification : Official Pharmacopoeia B.E. 2547 Ministerial Notification : Official Pharmacopoeia B.E. 2549 Ministerial Notification : Official Pharmacopoeia B.E. 2553 Ministerial Notification : Official Pharmacopoeia B.E. 2554 Ministerial Notification : Official Pharmacopoeia B.E. 2556

Recognized Official Pharmacopoeia Current Ministerial notification: Official Pharmacopoeia B.E. 2556 For Modern -Thai Pharmacopoeia II, Volume I, Part I and Supplements -Thai Herbal Pharmacopoeia Volume I and Supplements -The Fourth Edition of the International Pharmacopoeia and Supplements -The United States Pharmacopoeia, Thirty-Fourth Revision, and the National Formulary, Twenty-Ninth Edition and Supplements

Recognized Official Pharmacopoeia -British Pharmacopoeia 2011 Volume 1-5 and Addenda -British Pharmacopoeia (Veterinary) 2011 and Supplements -The Seventh Edition of the European Pharmacopoeia and Supplements

Thai Pharmacopoeia -Supervision of the drug product quality in Thailand is a shared authority among various Government agencies. -The Thai Pharmacopoeia Committee is responsible for establishing the Thai Pharmacopoeia (TP) which defines national standards to assure the quality of pharmaceutical products whereas the Food and, in co-operation with the Department of Medical Sciences, enforces them. -The TP specifications are thus national standards applicable to all pharmaceutical ingredients and preparations having their official names included in this Pharmacopoeia.

Thai Pharmacopoeia -TP Volume I contains the description of general method of analysis and quality specifications of selected raw materials 229 raw materials in Part 1 and 782 raw materials in Part 2, along with a chapter of 54 monographs and 21 appendices for biological products. -TP Volume II will be devoted mainly to the monographs of the selected pharmaceutical preparations

Thai Herbal Pharmacopoeia -Recognizing the importance of good quality crude drugs on the quality of finished herbal medicinal products, the Thai Herbal Pharmacopoeia was published by the Subcommittee on the Establishment of Thai Herbal Pharmacopoeia under the supervision of the Thai Pharmacopoeia Committee, of which the Department of Medical Sciences (DMSc), Ministry of Public Health serves as the secretariat office. -The Subcommittee is composed of DMSc officers from the Bureau of s and Narcotics, Medicinal Plant Research Institute, professors specialized in phytochemistry, botany and pharmacognosy from various universities.

Benefit of the recognized official pharmacopoeia To use as key reference to justify whether those interphase products fall under definition of under Article 4(2) of Act B.E 2510 To use as key reference to approve specification and control methods of any drugs where listed in official monograph applicable to new submission of MAA or Variation

Process for updating recognized Official Pharmacopoeia Thailand 1.Review by Sub-Committee or Working Group when new version of well recognized pharmacopoeia is publicly available 2.Seek public consultation from all stakeholders 3.Submit draft of Ministerial Notification to be reviewed by Committee for their positive opinion 4.Prepare Ministerial Notification as recommended by Committee for official endorsement by Minister 5. Publish in Royal Thai gazette

Criteria in recognition of pharmacopoeia Updated version of official pharmacopoeia Providing good reference to new and more precise analytical methods Providing important specification and control method to minimize risk Containing not too sophisticated methods to burden local industry Available and accessible in English version